We have investigated the possible roles of oncostatin M (OSM), which is a member of the interleukin-6 family of cytokines, in endometrial and endometriotic stromal cell growth. Endometrial and endometriotic stromal cells were collected from the uterus or ovarian chocolate cysts. We observed the expression of mRNA transcripts for OSM, OSM receptor subunit β, leukaemia inhibitory factor receptor subunit (LIFR), and glycoprotein 130 in endometrial and endometriotic stromal cells. We also examined the effects of OSM (0-50 ng/ml) and LIF (0-10 ng/ml) on endometrial and endometriotic stromal cell proliferation and evaluated the effects of OSM on endometrial stromal cell differentiation. The presence of 10-50 ng/ml OSM significantly suppressed endometrial stromal cell growth in secretory phase tissue but not in proliferative phase tissue. In contrast, stromal cells in endometriotic tissues were resistant to the inhibitory effects of OSM. Addition of LIF did not influence the growth of endometrial stromal cells. We also showed that 10 ng/ml OSM stimulated markers of differentiation causing increased prolactin secretion and cyclooxygenase-2 gene expression in endometrial stromal cells from the secretory phase. These results suggest that OSM may play a pivotal role in regulating the growth and differentiation of endometrial cells. Endometriotic cells may behave differently from normal endometrial cells in terms of the inhibitory response to OSM.
Introduction
As a pleiotrophic cytokine, OSM elicits many different biological functions in different cell types. Among these Oncostatin M (OSM), originally identified as a growth inhibitor functions, its ability to regulate cell growth and differentiation of A375 human melanoma cells, was cloned from the U937 is most notable. OSM stimulates the growth of normal human hepatopoietic cell line (Zarling et al., 1986; Linsley fibroblasts (Horn et al., 1990) , normal rabbit vascular smooth et al ., 1990) . OSM, which is produced by macrophages, muscle cells (Grove et al., 1993) , myeloma cells (Zhang et al. , monocytes, and activated T lymphocytes, is a member of the 1994), and AIDS-related Kaposi sarcoma cells (Miles et al., family of cytokines that includes IL-6, 1992; Nair et al., 1992) . OSM has also been shown to inhibit IL-11, OSM, leukaemia inhibitory factor (LIF), ciliary neurothe proliferation of a number of cell lines derived from human trophic factor (CNTF), and cardiotrophin-1 (CT-1) (Bazan tumours, including melanoma, breast carcinoma, and lung et Rose and Bruce, 1991; Davis et al., 1993 ; Du carcinoma (Zarling et al., 1986; Horn et al., 1990). and Williams, 1994; Penica et al., 1996) . These cytokines
We have previously shown that IL-6 inhibits proliferation exhibit very similar biological activities when they act on the of endometrial stromal cells derived from the secretory phase same cells. This functional similarity is now explained by of the menstrual cycle (Yoshioka et al., 1999) . In the present glycoprotein 130 (gp130), the common signalling subunit of study, we extended our investigation to the possible roles the receptors for these cytokines (Kishimoto et al., 1995) . The of other IL-6 family cytokines, and have examined the effects OSM receptor (OSMR) consists of gp130 and the OSMof OSM and LIF on the proliferation and differentiation of specific subunit (OSMRβ) that is structurally similar to gp130. endometrial and endometriotic stromal cells. In the human, the LIF receptor, which is the LIF-binding protein (LIFR) in association with gp130, also serves as a
Materials and methods
receptor for OSM (Gearing et al., 1992; Thoma et al., 1994) . Thus, OSM and LIF exhibit equivalent effects through the Isolation and culture of endometrial and endometriotic stromal cells LIFR, and OSM induces its unique activity through the OSMEndometrial tissues were obtained from the uteri of cycling premenopausal women who underwent hysterectomy for uterine specific receptor. leiomyoma (n ϭ 17) during the proliferative (n ϭ 6) or secretory prehybridized at 42°C for 2 h and then hybridized at 42°C overnight with biotinylated internal probes of OSM (5Ј-GAGGCGAACATCphase (n ϭ 11). The chocolate cyst lining of the ovaries in patients with endometriosis (n ϭ 9) was the source of endometriotic tissue.
CT-3Ј), OSMRβ (5Ј-GAATCTATAGGTTCAC-3Ј), LIFR (5Ј-GAAA-TGAATCCTTGT-3Ј), and gp130 (5Ј-CCAGATCCTTCAAAG-3Ј). Informed consent was obtained from all patients. The menstrual cycle phase was determined by measuring serum oestradiol and progesterone
The membranes were treated with streptavidin conjugated with alkaline phosphatase, and this was followed by chemiluminescence concentrations and by histological examination of the endometrium.
Stromal cells were collected from endometrial and endometriotic detection. Radiographic film was exposed to the membrane for 15 min at room temperature (Iwabe et al., 1998) . tissue according to a published method (Osteen et al., 1989) . The procedure has been described in detail previously (Iwabe et al., 1998) .
Endometrial stromal cells from the secretory phase were plated in 100 mm culture dishes at a concentration of 5-10ϫ10 5 cells per dish The tissues were minced and digested with 0.5% collagenase in Dulbecco's-modified Eagle's medium (DMEM) and and were allowed to proliferate until confluence (3-5 days). After the cells were preincubated in medium without serum for 24 h at (1:1, vol/vol) at 37°C for 60 min. The dispersed cells were filtered through a 70 µm nylon mesh to remove the undigested tissue 37°C, medium containing either 0.1% bovine serum albumin (BSA) alone or with 10 ng/ml of OSM (recombinant human OSM; R&D pieces containing the glandular epithelium. The filtered fraction was separated further from epithelial cell clumps by differential Systems, Minneapolis, MN, USA) was added and the cells were incubated for 72 h. Total RNA was then extracted from these sedimentation without centrifugation, i.e. 1 g. The medium containing stromal cells was filtered through 40 µm nylon mesh. Final purification incubated cells and subjected to RT-PCR as described above but involving 32 amplification cycles at 1 min at 94°C, 1 min at 55°C, was achieved by allowing stromal cells, which attach rapidly to plates, to adhere selectively to culture dishes for 30 min at 37°C in 2 min at 72°C, and 15 min at 72°C after each cycle. The following specific PCR primers for cyclo-oxygenase-2 (COX-2) were used 5% carbon dioxide in air. Non-adherent epithelial cells were removed.
Stromal cells were cultured in DMEM and F-12. Stromal cells in a (sense 5Ј-GCCAGATCACATTTGATTGACA-3Ј, antisense 5Ј-TCTTTGACTGTGGGAGGATACA-3Ј) (Kim et al., 1999) . The monolayer culture after the first passage were used for the experiments. Immunohistochemical analysis of isolated endometrial stromal cells internal probe of COX-2 (5Ј-ATTGCCCGACTCC-3Ј) was used for Southern blot analysis. Amplification of the COX-2 gene could be was performed with cytokeratin (Dako Japan Co. Ltd, Kyoto, Japan) as a marker of epithelial cells, vimentin (Dako) as a marker of stromal semiquantified as previously described (Kim et al., 1999) . Densitometric analysis of the PCR products was performed using NIH image cells, and factor VIII (Dako) as a marker of endothelial cells to confirm the purification of the stromal cells. The results showed that program software. The densitometric values of COX-2 mRNA were normalized with the corresponding ethidium bromide-stained the purity of stromal cells was Ͼ98%.
G3PDH mRNA.
RT-PCR analysis of gene expression
Tetrazolium dye assay for measuring cell proliferation Total RNA was extracted from the cultured endometrial and endomeProliferation of the cells was determined spectrophotometrically by triotic stromal cells by the guanidium thiocyanate method as described measuring the incorporation of tetrazolium dye (MTT assay). The previously (Yamazaki et al., 1996) . Reverse transcription (RT) of tetrazolium dye assay used in this study was a previously described RNA from cultured endometrial and endometriotic stromal cells into system (Iwabe et al., 1998) . Endometrial and endometriotic stromal cDNA and polymerase chain reaction (PCR) amplification was cells were cultured in culture medium with 10% fetal bovine serum performed with the Gene Amp RNA PCR Core Kit (Perkin-Elmer, to a seeding density of 3 to 5ϫ10 3 cells/well for 96-well tissue Norwalk, CT, USA). The ingredients of RT reaction were 2.5 IU/ml culture plates (100 µl/well), and incubated at 37°C for 12 h. The Moloney murine leukaemia virus reverse transcriptase, RNase medium was changed to a serum-free medium containing 1 mg/ml (1 IU/µl), MgCl 2 (5 mmol/l), PCR buffer II (1ϫ), dGTP (1 mmol/l), BSA. Cells were then treated continuously with 100 µl of various dATP (1 mmol/l), dTTP (1 mmol/l) and dCTP (1 mmol/l). The RT concentrations of OSM (0-50 ng/ml) or LIF (0-10 ng/ml, recombinant conditions were as follows: 10 min at 30°C, 20 min at 47°C, 5 min human LIF; Strathmann Biotech GMBH, Hannover, Germany). An at 99°C, and 5 min at 4°C. PCR amplification was carried out with antibody against human OSM (1 µg/ml monoclonal mouse anti-2 µl cDNA and 25 pmol of each primer in 25 µmol/l of a MgCl 2 human OSM; R&D Systems) was used to neutralize the specific solution (2 µmol/l), 1ϫPCR buffer II, distilled water (65.5 µl), and effects of OSM. An antibody against human IgG1 (1 µg/ml monoclonal Ampli Taq DNA polymerase (2.5 IU/100 ml; Perkin-Elmer). Samples mouse anti-human IgG1; Cosmo Bio Ltd, Tokyo, Japan) was used as were subjected to PCR involving 30-33 amplification cycles at 30 s a control. Each plate had one control row (6 wells) containing at 94°C, at 30 s at 60°C, at 1.5 min at 72°C, and 5 min at 75°C after cytokine-free medium. After the cells had been incubated for 72 h, each cycle. For PCR analysis, the following specific primers were 20 µl tetrazolium dye solution (2.5 mg/ml) was added to each well used: OSM: sense 5Ј-GACTGGCCGACTTAGAGC-3Ј, antisense and the plates were incubated for another 4 h. We chose 72 h 5Ј-GCATGAAGCGATGGTAGC-3Ј; OSMRβ: sense 5Ј-TTAAAGGCincubation time as has been previously described (Yoshioka et al., CAGAGGCTATGG-3Ј, antisense 5Ј-TTGACAGAAGAATTGTG-1999) . Dimethylsulphoxide (150 µl) was then added and the plates GAA-3Ј; LIFR: sense 5Ј-ATACAGATGGTGGAGTGG-3Ј, antisense were vigorously shaken on a plate shaker to render soluble the 5Ј-TGATGGGTGGACAATAGG-3Ј; gp130: sense 5Ј-ACAGATGtetrazolium dye-formazan product. Absorbance was measured at 590 AAGGTGGGAAGGAT-3Ј, antisense 5Ј-AGATGACATGCATGAAnm with a microplate reader (model 450; Bio-Rad Laboratories Inc, GACCC-3Ј; glycerol-3-phosphate dehydrogenase (G3PDH): sense Hercules, CA, USA). 5Ј-ACCACAGTCCATGCCATCAC-3Ј, antisense 5Ј-TCCACCACC-CTGTTGCTGTA-3Ј (Yamazaki et al., 1996; Iwabe et al., 1998;  Assay of prolactin secretion Schrell et al., 1998) . PCR products were resolved on 2% agarose gels with a low mol. wt DNA marker (ϫ174 digested with HaeIII).
Endometrial stromal cells from the secretory phase and endometriotic stromal cells were plated in 24-well dishes (Costar, Cambridge, MA, The PCR products were transferred onto a nylon membrane (Sarton; Sartorius, Göttingen, Germany) by means of a vacuum blotter with USA) at a concentration of 2ϫ10 5 cells per well. The cells were preincubated in medium without serum for 24 h and then received 0.4 mol/l sodium hydroxide and 1 mol/l NaCl. The DNA on the membrane was fixed with a UV cross-linker. The membranes were either media containing 0.1% BSA alone or media with various (10 ng/ml). 10 ng/ml OSM and 1 µg/ml of each antibody were used in the neutralization experiments.
Statistical analysis
The SD of the absorbance of tetrazolium dye assay (percentage of control value), and densitometric analysis of COX-2 mRNA prolactin tissues (n ϭ 11). The proliferation rate in cultures exposed to secretion assay were assessed by one-way analysis of variance, 10 ng/ml OSM was 66.6 Ϯ 6.3% of control values. The followed by the Fisher's protected least significant difference test.
inhibitory effects of OSM were negated by anti-OSM antibody
The data are presented as mean Ϯ SE. P Ͻ 0.05 was accepted as indicating statistical significance.
( Figure 2B ).
Since OSM and LIF exhibit similar effects through the LIFR in various cell types, we investigated the effects of LIF on No inhibitory effects on the growth of endometriotic stromal cells were observed with the various concentrations of OSM LIFR, and gp130 genes are expressed in both the endometrial and endometriotic stromal cells.
regardless of the menstrual cycle phase (Figure 3 ).
Effect of OSM on the differentiation of endometrial Effects of OSM and LIF on endometrial stromal cell proliferation stromal cells
It is well known that endometrial stromal cell differentiation To investigate the effects of OSM on endometrial stromal cell growth, tetrazolium dye assays were performed after the cells is associated with increased prolactin secretion (Maslar and Riddich, 1979) and COX-2 gene expression (Han et al., 1996) . were treated with various concentrations of OSM. OSM had no effect on the growth of stromal cells in tissue from the To determine whether OSM can induce differentiation of endometrial stromal cells of the secretory phase, we investiproliferative phase (n ϭ 6) ( Figure 2A ). On the other hand, the addition of concentrations of 10 and 50 ng/ml OSM induced gated the effects of OSM on the secretion of prolactin and COX-2 gene expression in endometrial cells from the secretory significant inhibition of cell proliferation from secretory phase phase. The addition of 1-10 ng/ml of OSM significantly functions as a differentiation factor causing a reduced rate of endometrial cell growth. stimulated prolactin secretion by endometrial stromal cells of the secretory phase ( Figure 4A ). The levels of prolactin OSM was initially described in 1986 as a growth regulatory molecule that could inhibit the growth of human melanoma produced by endometrial stromal cells were increased after 24 h culture ( Figure 4B ). In endometriotic stromal cells, OSM cells (Zarling et al., 1986) and stimulate the growth of several normal fibroblast cells (Horn et al., 1990) . Recently it was did not stimulate prolactin secretion ( Figure 4C ). We also showed that 10 ng/ml OSM could enhance the expression of reported that OSM inhibits the growth of primary normal mammary epithelial cells in a manner similar to its effect in the COX-2 gene in endometrial stromal cells of the secretory phase ( Figure 5) . breast cancer cells (Liu et al., 1997 (Liu et al., , 1998 . The growth inhibitory activity of OSM on primary normal mammary epithelial cells was associated with morphological changes
Discussion
(including cytoplasm enlargement and the appearance of We have demonstrated for the first time that gene expression of OSM and its receptor subunits are detected in both endometrial and endometriotic stromal cells. OSM could inhibit the growth of endometrial stromal cells derived from the secretory phase, but not the proliferative phase. OSM also enhanced prolactin production and COX-2 gene expression in endometrial stromal cells. Based upon these findings, we suggest that OSM Endometriotic stromal cells were incubated in medium containing OSM (0 and 1 ng/ml) for 24 h (C). The culture supernatants were used to measure prolactin in duplicate using prolactin radioimmunoassay kits. The values were adjusted by the number of cultured cells. *P Ͻ 0.05; **P Ͻ 0.01, versus control value. intracellular vacuoles) which are attributed to a cellular differrelated substances. Recent studies have suggested that a crosstalk between steroid hormones and cytokines signalling pathentiation process (Zhang et al., 1995) . Similarly, we found that the inhibition in proliferation of endometrial stromal cells ways is important for understanding cytokine actions. Further studies are needed to resolve these issues. from the secretory phase was associated with the decidualization of stromal cells. Although we did not find apparent It is also important to note that endometrial cells derived from different phases of the menstrual cycle, but cultured under morphological changes in cultured stromal cells, differentiation was suggested by the increased secretion of prolactin and uniform culture conditions, may not resemble the condition of either the proliferative or secretory phase. Therefore, data expression of COX-2 after OSM treatment.
Recent evidence shows that growth factors, such as epiappearing to show that cytokines such as OSM affect endometrial tissue differently depending on the menstrual cycle should dermal growth factor, mediate the growth-promoting action of oestrogen in uterine tissue (Nelson et al., 1991) . Alternatively, be evaluated with caution. Growth factors and cytokines in peritoneal fluid have been oestrogen may enhance epithelial cell proliferation by blocking the synthesis of cell proliferation inhibitors secreted by stromal postulated to play a role in the pathogenesis of endometriosis by facilitating the growth of endometrial cells at ectopic sites cells. Current results, in conjunction with several recent observations, support the contention that IL-6 and OSM may be (Halme et al., 1987) . We have recently demonstrated that IL-8 levels in peritoneal fluid are elevated in patients with among the inhibitory factors that control homeostasis of the endometrium (Tabibzadeh et al., 1989; Zarmakoupis et al., endometriosis and that IL-8 stimulates proliferation of the cultured endometrial and endometriotic stromal cells (Iwabe 1995; Yoshioka et al., 1999) .
The biological functions of OSM and LIF have been shown et al., 2000) . In contrast, IL-6 had inhibitory effects on the growth of endometrial cells, but endometriotic cells were to overlap in several cell types in which either the LIF receptor only or both the LIF and OSM-specific receptors are expressed.
resistant to IL-6 growth inhibition (Yoshioka et al., 1999) . Similarly, inhibition of proliferation by OSM was not observed On the other hand, OSM, but not LIF, inhibits the growth of A375 human histiocytic melanoma cells (Zarling et al., 1986;  in the stromal cells of ovarian chocolate cysts. The results suggest that endometriotic cells have different biological char- Brown et al., 1987; Malik et al., 1989) as well as a variety of tumour cell lines of lung, breast, ovary, and stomach origin acteristics, particularly in their response to the IL-6 family of cytokines, as compared with eutopic endometrial cells. An (Horn et al., 1990) . In addition, LIF has no effect on normal mammary epithelial cell growth in contrast to the inhibitory increasing body of evidence points to biochemical differences between the endometriotic tissues and endometrium. Further activity of OSM (Liu et al., 1998) . Similarly, growth inhibition by OSM, but not LIF, was observed in the endometrial cells studies directed toward the regulatory mechanism of IL-6 and OSM response in endometrial and endometriotic tissues are collected during the secretory phase. LIF binds only to LIFR, whereas OSM binds to the OSM-specific receptor with a necessary to resolve these issues.
In conclusion, OSM may induce a differentiation process higher affinity than it binds LIFR (Mosley et al., 1996) . Based on these data, growth inhibition of endometrial stromal cells of the endometrium, resulting in a reduced rate of growth and induction of differentiation. by OSM may be mediated by the OSM-specific receptor but not by LIFR.
In a previous study, we found that IL-6 inhibits proliferation 
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